TNF and hydrops fetalis: Several studies have addressed that tumor necrosis factor inhibitors (TNFi) therapy might improve the cardiac function by lowering the overall inflammatory state, thus slowing down the process of coronary atherosclerosis and subsequently decreasing the risk of developing HF in AA [21–23].